The cancer tumor profiling market size has observed significant expansion in recent years. It is expected to grow from $13 billion in 2024 to $14.99 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The increase in this period can be attributed to the growing incidence of cancer cases, advances in precision medicine initiatives and research collaborations, improvement in cancer diagnostics and early detection methods, availability of numerous targeted therapy options, and a supportive regulatory framework for cancer profiling tests.
In the near future, the cancer tumor profiling market size is projected to experience rapid growth. It is predicted to shoot up to $25.33 billion in 2029 at a CAGR of 14.0%. The growth in the forecast period can be attributed to the expansion of immunotherapy and immunoprofiling in cancer treatment, development of liquid biopsy and non-invasive tumor profiling methods, and the growing demand for rare and orphan cancer subtype profiling. Major trends expected in the forecast period include integration of tumor profiling into routine clinical practice and advances in genomics and next-generation sequencing (ngs) technologies.
Get Your Free Sample of The Global Cancer Tumor Profiling Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp
What Drives The Surge In The Cancer Tumor Profiling Market?
The rising incidences of cancer globally is anticipated to drive the growth of the cancer and tumor profiling market forward. Cancer, a disease characterized by uncontrolled growth and spread of cells, has seen an increasing number of cases, hence the growing demand for cancer tumor profiling. It aids doctors in determining the disease’s severity. For instance, in 2024, the US-based professional organization, the American Cancer Society, reported that cancer cases had risen to 2 million from the preceding year’s 1.9 million cases. This surge in the global cancer incidence form the key growth driver of the cancer and tumor profiling market.
How Is The Cancer Tumor Profiling Market Segmented?
1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Who Are The Leading Players In The Cancer Tumor Profiling Market?
Among the major companies operating in the cancer tumor profiling market are F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid.
What Trends Are Spectated In The Cancer Tumor Profiling Market?
The rise of research and development activities forms a key trend in the cancer and tumor profiling market. Companies operating in the sector are focusing on research and development efforts to meet consumer demand and reinforce their standing. QIAGEN N.V, a German company that develops sample and assay technology for various applications, announced the Conformitè Europëenne (CE)-marking and commercialization of therascreen PIK3CA RGQ PCR Kit in Europe. This has enabled breast cancer patients with PIK3CA mutations to be identified.
Which Is The Fastest Growing Region In The Cancer Tumor Profiling Market?
In terms of geographical location, North America was the largest region in the cancer and tumor profiling market in 2024. However, the Asia-Pacific region is expected to become the fastest-growing region in the forecast period. The regions covered in the cancer and tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Cancer Tumor Profiling Market Report 2025 Offer?
Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. This profiling can aid in treatment planning and predicting if cancer will recur or spread to other parts of the body. Furthermore, The Cancer Tumor Profiling Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053
About The Business Research Company
Learn More About the Business Research Company. With over 15000+ reports spanning 27 industries and covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Leveraging 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
